MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202541124413 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Dec. 10, 2025, for '3d printing of biocompatible scaffolds using green-synthesized nanoparticles from sphagneticola trilobala extracts for wound healing applications.'

Inventor(s) include Gomathy Baskar; Rajeshkumar. S; and Deepak Nallaswamy Veeraiyan.

The application for the patent was published on Feb. 13, under issue no. 07/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to the design and fabrication of biocompatible scaffolds for wound healing, wherein three-dimensional (3D) printing technology is combined with green- synthesized nanoparticles derived from Sphagneticola trilobata plant extracts. The invention outlines an eco-friendly method for synthesizing nanoparticles using the extract's phytochemicals as natural reducing and stabilizing agents, eliminating the need for toxic chemicals. Nanoparticles are incorporated into biocompatible polymeric matrices like polycaprolactone, polylactic acid, chitosan, or gelatin, processed through 3D printing to create scaffolds with controlled porosity, mechanical stability, and biodegradability. The resulting scaffolds demonstrate enhanced biocompatibility, antimicrobial and antioxidant activity, and provide an optimized microenvironment for cellular adhesion, proliferation, and tissue regeneration. The invention provides a sustainable, cost-effective, -and-multifunctional platform for advanced wound care and tissue engineering applications, allowing scaffold customization to patient-specific wound geometries and therapeutic agents."

Disclaimer: Curated by HT Syndication.